Author Archives: clairesophie7389

The freshest class of antidiabetic meds is known as the sodium-glucose cotransporter 2, or SGLT2, inhibitors. It incorporates – canagliflozin, empagliflozin, and dapagliflozin. The SGLT2 inhibitors. They work by expanding the measure of sugar discharged by the kidneys. In 2013, the US Food and Drug organization (FDA) and the Australian Department of Health endorsed theContinue reading “Type 2 Diabetes – A New Class of Antidiabetic Drugs”